The Indian pharmaceutical market could witness a sharp deceleration in growth in 2020 amid COVID-19 related disruptions, along the lines of similar declines anticipated in some other Asian nations, an early assessment of the situation by IQVIA has suggested.
The IQVIA study estimates that growth in the Indian pharmaceutical market could slide to 1-5% in 2020 from earlier predictions...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
